Anzahl der Publikationen: 6
Zeitschriftenartikel
Paluch-Shimon, S.; Cardoso, F.; Partridge, A. H.; Abulkhair, O.; Azim, H. A.; Bianchi-Micheli, G.; Cardoso, M. J.; Curigliano, G.; Gelmon, K. A.; Gentilini, O.; Harbeck, N.; Kaufman, B.; Kim, S. B.; Liu, Q.; Merschdorf, J.; Poortmans, P.; Pruneri, G.; Senkus, E.; Sirohi, B.; Spanic, T.; Sulosaari, V.; Peccatori, F. und Pagani, O.
(2022):
ESO-ESMO fifth international consensus guidelines for breast cancer in young women (BCY5).
In: Annals of Oncology, Bd. 33, Nr. 11: S. 1097-1118
Paluch-Shimon, S.; Cardoso, F.; Partridge, A. H.; Abulkhair, O.; Azim, H. A.; Bianchi-Micheli, G.; Cardoso, M-J; Curigliano, G.; Gelmon, K. A.; Harbeck, N.; Merschdorf, J.; Poortmans, P.; Pruneri, G.; Senkus, E.; Spanic, T.; Stearns, V.; Wengstrom, Y.; Peccatori, F. und Pagani, O.
(2020):
ESO-ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4).
In: Annals of Oncology, Bd. 31, Nr. 6: S. 674-696
Rugo, H. S.; Dieras, V.; Gelmon, K. A.; Finn, R. S.; Slamon, D. J.; Martin, M.; Neven, P.; Shparyk, Y.; Mori, A.; Lu, D. R.; Bhattacharyya, H.; Bartlett, C. Huang; Iyer, S.; Johnston, S.; Ettl, J. und Harbeck, N.
(2018):
Impact of palbociclib plus letrozole on patient-reported health-related quality of life: results from the PALOMA-2 trial.
In: Annals of Oncology, Bd. 29, Nr. 4: S. 888-894
Dieras, V.; Harbeck, N.; Joy, A. A.; Gelmon, K. A.; Ettl, J.; Verma, S.; Lu, D.; Gauthier, E. R.; Schnell, P.; Mori, A.; Rugo, H. S. und Finn, R. S.
(2017):
PALOMA-2: Neutropenia (NP) patterns in patients (Pts) with estrogen receptor-positive (ER plus )/human epidermal growth factor receptor 2-negative (HER2-) first-line advanced breast cancer (ABC) receiving palbociclib plus letrozole (P plus L).
In: Annals of Oncology, Bd. 28
Cardoso, F.; Harbeck, N.; Barrios, C. H.; Bergh, J.; Cortés, J.; El Saghir, N.; Francis, P. A.; Hudis, C. A.; Ohno, S.; Partridge, A. H.; Sledge, G. W.; Smith, I. E. und Gelmon, K. A.
(2017):
Research needs in breast cancer.
In: Annals of Oncology, Bd. 28, Nr. 2: S. 208-217
Rugo, H.; Dieras, V.; Gelmon, K. A.; Finn, R.; Slamon, D.; Miguel, M.; Neven, P.; Ettl, J.; Shparyk, Y.; Mori, A.; Lu, D. R.; Bhattacharyya, H.; Bartlett, C. H.; Iyer, S.; Johnston, S. und Harbeck, N.
(2016):
Impact of palbociclib plus letrozole on health related quality of life (HRQOL) compared with letrozole alone in treatment naive postmenopausal patients with ER+HER2-metastatic breast cancer (MBC): results from PALOMA-2.
In: Annals of Oncology, Bd. 27
Diese Liste wurde am
Sat Jan 4 20:45:13 2025 CET
erstellt.